Clinical Trials Posts

Huntsman Translational Scholars: Deborah Stephens, DO

Huntsman Translational Scholars: Deborah Stephens, DO

HCI established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Deborah Stephens, DO, was recently honored with a Huntsman Translational Scholar award. She is the physician leader of the Hematology Clinical Trials at Huntsman Cancer Institute and is also an Assistant Professor in the Division of Hematology and Hematologic Malignancies at the University of Utah.

Read More

cancer care, cancer research, clinical trials, lymphoma, leukemia

Talks with Docs: Theresa Werner, MD

Talks with Docs: Theresa Werner, MD

Huntsman Cancer Institute celebrates International Women's Day 2018 in a conversation with Dr. Theresa Werner. Her patients juggle treatment with lives that often include work, a relationship, and motherhood. She talks with us about the optimistic women she treats in clinic and a stylish first lady of the United States she would trade lives with for a day.

Read More

talks with docs, cancer care, gynecologic cancer, breast cancer, ovarian cancer, uterine cancer, cervical cancer, endometrial cancer, clinical trials

HCI Physician Receives Award from National Cancer Institute

HCI Physician Receives Award from National Cancer Institute

Congratulations to Theresa Werner, MD, Huntsman Cancer Institute (HCI) investigator and University of Utah assistant professor of medicine, who received a 2016 Cancer Clinical Investigator Team Leadership Award from the National Cancer Institute (NCI). Dr. Werner serves as medical director of the HCI Clinical Trials Office and manages an extensive portfolio of cancer clinical studies.

Read More

clinical trials, cancer research, gynecologic cancer,

Providing the Last, Best Hope

Providing the Last, Best Hope

Clinical trials for some cancer patients may be the last, best hope for survival. A phase I trial is the first time a treatment is studied in people—usually a select number of patients who have not had success with other treatments. A rigorous process of approval takes place before doctors test these new therapies on patients for the first time.

Read More

clinical trials, cancer research,

New Treatment Reduces Precancerous Polyps in Hereditary Cancer Patient

New Treatment Reduces Precancerous Polyps in Hereditary Cancer Patient

Inheriting a mutation in the APC gene leads to a nearly 100% lifetime risk of colorectal cancer. While colon cancer can be kept at bay by removing the large intestine, these patients also have up to a 15% risk of getting cancer in the small intestine, which is the leading cause of cancer death in this patient group. A new study published in the Journal of the American Medical Association (JAMA) has identified the first prevention treatment for these patients, a two-drug combination that significantly reduces the number and size of precancerous polyps in the small intestine.

Read More

genetics, colorectal cancer, cancer research, clinical trials

The Art and Science of Clinical Research Coordination

The Art and Science of Clinical Research Coordination

Walking into clinic, I found the patient and his wife looking tired and apprehensive. From what I knew of his medical history, his cancer had not responded to any standard treatments, each drug failing to restrain the tumor’s advance for more than a few months. The patient and his wife had talked to their local cancer doctor about clinical trials, had traveled hundreds of miles to Huntsman Cancer Institute, and were clearly anxious to begin the discussion.

Read More

clinical trials, patient stories